Skip to collection list Skip to video grid
Skip to collection list Skip to video grid

四月新聞

20240228 小細胞肺癌占比高 免疫抑制劑合併化療納健保給付

肺癌為國人十大死因排名第一,其中有號稱肺癌惡霸的小細胞肺癌,突破10多年治療困境,將免疫制劑納入健保,患者平均每年可以省下約145萬元。

Read More
Read Less

categories

View more in
四月新聞

Currently loaded videos are 1 through 15 of 237 total videos.

First page loaded, no previous page available
Load Next Page